Merck&#39;s Vioxx Should Have Been Recalled Years Ago, Lancet Says
138190
Merck &amp; Co.&#39;s Vioxx painkiller&#39;s heart risk was evident in studies four years before the drug was recalled -- and it should have been pulled from the market then, according to a study published in the medical journal Lancet.
547958
Merck officials had evidence as far back as 2001 that Vioxx might not help thousands of users of the arthritis and pain drug.
521954
NEW YORK (CBS) The recent recall of the arthritis drug Vioxx has a lot of patients worried about the contents of their medicine cabinets and wondering what the alternatives might be.
209879
A Wall Street analysis suggests the Vioxx recall may cost the pharmaceutical firm Merck as much as $18 billion over the next decade.
28228
US drugs giant Merck &amp; Co Inc. should have pulled its Vioxx painkiller from the market four years ago, because data showing it raised the risk of heart attacks has existed since 2000, Swiss scientists said on Friday.
415386
The recall of Merck&#39;s arthritis drug Vioxx has drawn attention to drug overall safety, more specifically, a similar drug known as Celebrex, by the drug maker Pfizer.
523465
Merck &amp; Co., the US drug maker that recalled its Vioxx painkiller because of a link to heart disease, said short-term studies show the companyâs planned successor pill, Arcoxia, is safer.
247288
Merck &amp; Co. withdrew its Vioxx painkiller, which generated $2.5 billion in sales last year, because of a link to heart attacks and strokes.
206148
Merck reduced its 2004 forecast by 50 cents to 55 cents because of lost revenues. The move followed the recall of Vioxx from the global market on September 30th, due to its association with increased risk of heart attacks.
384984
Soon after the anti-arthritis and painkiller drug Vioxx was approved by the Food and Drug Administration in 1999, credible questions surfaced about the risk of serious cardiovascular problems in people who took it.
519933
NEW YORK - Should Merck have conducted a bigger trial to test the safety of its arthritis drug Vioxx? Merck (nyse: MRK - news - people ) pulled Vioxx from the market two weeks ago, but questions about the
125028
Drug company Merck has removed its painkiller Vioxx because of data showing an increased risk of heart attack and stroke.
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
81161
Drug giant Merck pulled its painkiller Vioxx because it increased the risk of heart attacks and strokes. Now the company may face thousands of lawsuits.
62492
Merck&#39;s recall of its arthritis pain drug, Vioxx, because of elevated risks of heart attack and stroke has obscured another important issue that Congress, in investigating the matter, must face squarely and deal with: What happens when pharmaceutical
323949
Pharmaceutical giant Merck &amp; Co Inc. had evidence by 2000 that its painkiller Vioxx, which was pulled off the market on Sept. 30, was not safe, a heart specialist told CBS News program &quot;60 Minutes&quot; on Sunday.
140168
Merck &amp; Co Inc. on Thursday pulled its arthritis drug Vioxx off the market because it increases the risk of heart attack and stroke, a move that sent the company&#39;s